Clinical trial
Bone Marrow Transplantation in Treating Patients With Leukemia
NCT00006451 · Masonic Cancer Center, University of Minnesota, Other · Withdrawn
Key facts
| NCT number | NCT00006451 |
|---|---|
| Title | Bone Marrow Transplantation in Treating Patients With Leukemia |
| Official title | T-cell Depletion In Unrelated Donor Marrow Transplantation |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Leukemia, Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | anti-thymocyte globulin, cyclophosphamide, cyclosporine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy |
| Enrollment | 0 |
| Start date | Apr 1, 1996 |
| Primary completion | Nov 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | Jun 9, 2004 |
| Last update posted | Jan 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: